KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Exchange Rate Effect (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Exchange Rate Effect for 3 consecutive years, with $1.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Exchange Rate Effect rose 1050.35% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Jun 2025, up 364.73%, and an annual FY2025 reading of $1.3 million, up 235.68% over the prior year.
  • Exchange Rate Effect was $1.4 million for Q2 2025 at Biocryst Pharmaceuticals, up from $451000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.4 million in Q2 2025 and bottomed at -$1.3 million in Q4 2024.
  • Average Exchange Rate Effect over 3 years is $123600.0, with a median of $78500.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect tumbled 349.81% in 2024, then surged 1050.35% in 2025.
  • Year by year, Exchange Rate Effect stood at $522000.0 in 2023, then plummeted by 349.81% to -$1.3 million in 2024, then skyrocketed by 204.22% to $1.4 million in 2025.
  • Business Quant data shows Exchange Rate Effect for BCRX at $1.4 million in Q2 2025, $451000.0 in Q1 2025, and -$1.3 million in Q4 2024.